Corbus Pharmaceuticals Holdings Inc

NASDAQ:CRBP   3:59:58 PM EDT
1.22
0.00 (0.00%)
4:03:05 PM EDT: $1.23 +0.01 (+0.82%)
Other Pre-Announcement

Corbus Pharmaceuticals Reports Third Quarter Financial Results And Provides Corporate Updates

Published: 11/10/2020 13:02 GMT
Corbus Pharmaceuticals Holdings Inc (CRBP) - Corbus Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Updates.
Q3 Loss per Share $0.43.
Q3 Earnings per Share Estimate $-0.42 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Revenue Decreased by About $1.4 Million From Q3 of 2019 to $1.2 Million.
Corbus Pharmaceuticals Holdings- Expects Cash & Cash Equivalents With Proceeds From Milestone Payment to Fund Operations Beyond Q2 of 2022.